Johnson & Johnson One-Shot Coronavirus Vaccine Approved in the U.S.
A Centers for Disease Control advisory panel on Sunday recommended Johnson & Johnson’s one-shotvaccine for people 18 and over, clearing the way for inoculations to begin as soon as this week. The recommendation comes one day after the (FDA) on Saturday authorized Johnson & Johnson‘s COVID-19 vaccine for emergency use.
“The authorization of this vaccine expands the availability of vaccines, the best medical prevention method for COVID-19, to help us in the fight against this pandemic, which has claimed over half a million lives in the United States,” Acting FDA Commissioner Dr. Janet Woodcock said Saturday.
“The FDA, through our open and transparent scientific review process, has now authorized three COVID-19 vaccines with the urgency called for during this pandemic, using the agency’s rigorous standards for safety, effectiveness and manufacturing quality needed to support emergency use authorization.”
The vaccine is the third to be approved for use in the U.S., and the first that requires only one shot. The FDA‘s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously to recommend authorizing the vaccine by Janssen, a division of Johnson & Johnson, on Friday. The committee provides expert advice to the FDA, but does not have final say on approval.